SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC. 20549
FORM
10-QSB
(Mark
One)
x |
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
For
the
quarterly period ended December
31, 2007
or
o |
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
Commission
file number 0-15235
Mitek
Systems, Inc.
(Exact
name of small business issuer as specified in its charter)
Delaware
|
|
87-0418827
|
(State
or other jurisdiction of incorporation
or organization)
|
|
(I.R.S.
Employer Identification
No.)
|
8911
Balboa Ave., Suite B, San Diego,
California
|
|
92123
|
(Address
of principal executive
offices)
|
|
(Zip
Code)
|
Issuer's
telephone number (858)
503-7810
(Former
name, former address and former fiscal year, if changed since last
report)
Check
whether the issuer (1) filed all reports required to be filed by Section 13
or
15(d) of the Securities Exchange Act of 1934 during the past 12 months (or
for
such shorter period that the registrant was required to file such reports),
and
(2) has been subject to such filing requirements for the past 90 days.
Yes x
No o
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Yes
o No
x
There
were 16,751,137 shares outstanding of the registrant's Common Stock as of
February 4, 2008.
Transitional
Small Business Disclosure Format: Yes o No x
MITEK
SYSTEMS, INC.
FORM
10-QSB
For
the Quarter Ended December 31, 2007
INDEX
|
|
|
Page
|
|
|
|
|
Part
I. Financial Information |
|
|
|
|
|
Item
1. |
Financial
Statements |
|
|
|
|
|
|
a)
|
Balance
Sheet
|
|
|
|
As
of December 31, 2007 (Unaudited) and September 30, 2007
|
1
|
|
|
|
|
|
b)
|
Statements
of Operations
|
|
|
|
for
the Three Months Ended December 31, 2007 and 2006
(Unaudited)
|
2
|
|
|
|
|
|
c)
|
Statements
of Cash Flows
|
|
|
|
for
the Three Months Ended December 31, 2007 and 2006
(Unaudited)
|
3
|
|
|
|
|
|
d)
|
Notes
to Unaudited Financial Statements
|
4
|
|
|
|
|
Item
2. |
|
Management’s Discussion
and Analysis or Plan of Operation |
10
|
|
|
|
|
Item
3. |
|
Controls
and Procedures |
18
|
|
|
|
|
Part
II. Other Information |
|
|
|
|
|
Item
1. |
|
Legal
Proceedings |
18
|
|
|
|
|
Item
6. |
|
Exhibits
and Reports on Form 8-K |
18
|
|
|
|
|
Signature |
19
|
ITEM
1
FINANCIAL
INFORMATION
MITEK
SYSTEMS, INC.
BALANCE
SHEET
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
ASSETS
|
|
|
|
|
|
CURRENT
ASSETS:
|
|
|
|
|
|
Cash
and cash equivalents
|
|
$ |
1,498,691
|
|
$
|
2,096,282
|
|
Accounts
receivable including related party of $222,166 and $203,466,
respectively,
|
|
|
879,493
|
|
|
542,009
|
|
net
of allowance of $18,977 in both periods
|
|
|
|
|
|
|
|
Inventory,
prepaid expenses and other current assets
|
|
|
66,343 |
|
|
99,476
|
|
Total
current assets
|
|
|
2,444,527 |
|
|
2,737,767
|
|
|
|
|
|
|
|
|
|
PROPERTY
AND EQUIPMENT-net
|
|
|
85,624
|
|
|
77,827
|
|
OTHER
ASSETS
|
|
|
29,465 |
|
|
29,465
|
|
TOTAL
ASSETS
|
|
$
|
2,559,616
|
|
$
|
2,845,059
|
|
|
|
|
|
|
|
|
|
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT
LIABILITIES:
|
|
|
|
|
|
|
|
Accounts
payable
|
|
$ |
196,314 |
|
$
|
120,519
|
|
Accrued
payroll and related taxes
|
|
|
291,909 |
|
|
249,036
|
|
Deferred
revenue
|
|
|
332,187 |
|
|
541,010
|
|
Other
accrued liabilities
|
|
|
43,541 |
|
|
31,510
|
|
Total
current liabilities
|
|
|
863,951 |
|
|
942,075
|
|
|
|
|
|
|
|
|
|
Deferred
rent
|
|
|
48,577 |
|
|
44,596
|
|
TOTAL
LIABILITIES
|
|
|
912,528
|
|
|
986,671
|
|
|
|
|
|
|
|
|
|
STOCKHOLDERS'
EQUITY:
|
|
|
|
|
|
|
|
Preferred
stock, $0.001 par value, 1,000,000 shares
authorized,
|
|
|
|
|
|
|
|
none
issued and outstanding
|
|
|
- |
|
|
-
|
|
Common
stock, $.001 par value; 40,000,000 shares
authorized,
|
|
|
|
|
|
|
|
16,751,137
issued and outstanding
|
|
|
16,751 |
|
|
16,751
|
|
Additional
paid-in capital
|
|
|
14,653,194 |
|
|
14,582,894
|
|
Accumulated
deficit
|
|
|
(13,022,857 |
) |
|
(12,741,257
|
)
|
Total
stockholders' equity
|
|
|
1,647,088 |
|
|
1,858,388
|
|
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
$
|
2,559,616
|
|
$
|
2,845,059
|
|
The
accompanying notes form an integral part of these financial
statements.
STATEMENTS
OF OPERATIONS
(Unaudited)
|
|
THREE
MONTHS ENDED
|
|
|
|
December
31,
|
|
|
|
2007
|
|
2006
|
|
NET
SALES
|
|
|
|
|
|
Software
including approximately $227,000 and $24,000
|
|
$
|
785,261
|
|
$
|
920,456
|
|
to
a related party, respectively
|
|
|
|
|
|
|
|
Professional
Services, education and other including approximately
|
|
|
|
|
|
|
|
$9,000
and $86,000 to a related party, respectively
|
|
|
478,338
|
|
|
518,376
|
|
|
|
|
1,263,599
|
|
|
1,438,832
|
|
|
|
|
|
|
|
|
|
COSTS
AND EXPENSES:
|
|
|
|
|
|
|
|
Cost
of sales-software
|
|
|
133,087
|
|
|
134,656
|
|
Cost
of sales-professional services, education and other
|
|
|
41,777
|
|
|
22,106
|
|
Operations
|
|
|
24,399
|
|
|
21,982
|
|
Selling
and marketing
|
|
|
345,506
|
|
|
255,019
|
|
Research
and development
|
|
|
530,887
|
|
|
501,906
|
|
General
and administrative
|
|
|
472,463
|
|
|
795,814
|
|
Total
costs and expenses
|
|
|
1,548,119
|
|
|
1,731,483
|
|
OPERATING
LOSS
|
|
|
(284,520
|
)
|
|
(292,651
|
)
|
|
|
|
|
|
|
|
|
OTHER
INCOME (EXPENSE):
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
-
|
|
|
(5,916
|
)
|
Interest
and other income
|
|
|
2,920
|
|
|
4,423
|
|
Total
other income (expense) - net
|
|
|
2,920
|
|
|
(1,493
|
)
|
|
|
|
|
|
|
|
|
LOSS
BEFORE INCOME TAXES
|
|
|
(281,600
|
)
|
|
(294,144
|
)
|
|
|
|
|
|
|
|
|
PROVISION
FOR INCOME TAXES
|
|
|
-
|
|
|
-
|
|
NET
LOSS
|
|
$
|
(281,600
|
)
|
$
|
(294,144
|
)
|
|
|
|
|
|
|
|
|
NET
LOSS PER SHARE - BASIC AND DILUTED
|
|
$
|
(0.02
|
)
|
$
|
(0.02
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WEIGHTED
AVERAGE NUMBER OF
|
|
|
|
|
|
|
|
COMMON
SHARES OUTSTANDING - BASIC AND DILUTED
|
|
|
16,751,137
|
|
|
16,748,974
|
|
The
accompanying notes form an integral part of these financial
statements.
MITEK
SYSTEMS, INC.
(Unaudited)
|
|
THREE
MONTHS ENDED
|
|
|
|
December
31,
|
|
|
|
2007
|
|
2006
|
|
OPERATING
ACTIVITIES
|
|
|
|
|
|
Net
loss
|
|
$
|
(281,600
|
)
|
$
|
(294,144
|
)
|
Adjustments
to reconcile net loss to net cash provided by
|
|
|
|
|
|
|
|
(used
in) operating activities:
|
|
|
|
|
|
|
|
Depreciation
and amortization
|
|
|
10,348
|
|
|
11,288
|
|
Provision
(recoveries) for bad debts
|
|
|
-
|
|
|
(15,000
|
)
|
Stock
based compensation expense
|
|
|
70,300
|
|
|
44,349
|
|
Changes
in assets and liabilities:
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
(337,484
|
)
|
|
231,910
|
|
Inventory,
prepaid expenses, and other assets
|
|
|
33,134
|
|
|
74,549
|
|
Accounts
payable
|
|
|
75,795
|
|
|
182,553
|
|
Accrued
payroll and related taxes
|
|
|
42,873
|
|
|
(14,374
|
)
|
Deferred
revenue
|
|
|
(208,823
|
)
|
|
(135,905
|
)
|
Other
accrued liabilities
|
|
|
12,031
|
|
|
20,419
|
|
Deferred
rent
|
|
|
3,981
|
|
|
6,371
|
|
Net
cash provided by (used in) operating activities
|
|
|
(579,445
|
)
|
|
112,016
|
|
|
|
|
|
|
|
|
|
INVESTING
ACTIVITIES
|
|
|
|
|
|
|
|
Purchases
of property and equipment
|
|
|
(18,146
|
)
|
|
-
|
|
Net
cash used in investing activities
|
|
|
(18,146
|
)
|
|
-
|
|
|
|
|
|
|
|
|
|
FINANCING
ACTIVITIES
|
|
|
|
|
|
|
|
Proceeds
from exercise of stock options
|
|
|
-
|
|
|
4,636
|
|
Net
cash provided by financing activities
|
|
|
-
|
|
|
4,636
|
|
|
|
|
|
|
|
|
|
NET
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
|
|
(597,591
|
)
|
|
116,652
|
|
|
|
|
|
|
|
|
|
CASH
AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
|
|
|
2,096,282
|
|
|
2,331,011
|
|
|
|
|
|
|
|
|
|
CASH
AND CASH EQUIVALENTS AT END OF PERIOD
|
|
$
|
1,498,691
|
|
$
|
2,447,663
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUPPLEMENTAL
DISCLOSURE OF
|
|
|
|
|
|
|
|
CASH
FLOW INFORMATION
|
|
|
|
|
|
|
|
Cash
paid for interest
|
|
$
|
-
|
|
$
|
-
|
|
Cash
paid for income taxes
|
|
$
|
-
|
|
$
|
-
|
|
The
accompanying notes form an integral part of these financial
statements.
MITEK
SYSTEMS, INC.
NOTES
TO
FINANCIAL STATEMENTS
1. Basis
of Presentation
The
accompanying balance
sheet as of September 30, 2007, which has been derived from audited
financial statements, and the unaudited
interim financial statements of Mitek Systems, Inc. (the “Company”) have
been prepared in accordance with the instructions to Form 10-QSB and, therefore,
do not include all information and footnote disclosures that are otherwise
required by Regulation S-B and that will normally be made in the Company's
Annual Report on Form 10-KSB. Refer to the Company’s financial statements on
Form 10-KSB for the year ended September 30, 2007 for additional information.
The financial statements do, however, reflect all adjustments (solely of a
normal recurring nature) which are, in the opinion of management, necessary
for
a fair statement of the results of the interim periods presented.
Results
for the three months ended December 31, 2007 are not necessarily indicative
of
results which may be reported for any other interim period or for the year
as a
whole.
2. Recently
Issued Accounting Pronouncements
In
September 2006, the FASB issued SFAS No. 157 Fair
Value Measurements
(“SFAS
157”). SFAS 157 provides a new single authoritative definition of fair value and
provides enhanced guidance for measuring the fair value of assets and
liabilities and requires additional disclosures related to the extent to which
companies measure assets and liabilities at fair value, the information used
to
measure fair value, and the effect of fair value measurements on earnings.
SFAS
157 is effective for fiscal years beginning after November 15, 2007.We are
currently assessing the impact, if any, of SFAS 157 on our financial position,
results of operation, or cash flows.
In
February 2007, the FASB issued SFAS No. 159, The
Fair Value Option for Financial Assets and Financial Liabilities —
including an amendment of SFAS No. 115, which
allows measurement at fair value of eligible financial assets and liabilities
that are not otherwise measured at fair value. If the fair value option for
an
eligible item is elected, unrealized gains and losses for that item shall be
reported in current earnings at each subsequent reporting date. SFAS
No. 159 also establishes presentation and disclosure requirements designed
to draw comparison between the different measurement attributes the company
elects for similar types of assets and liabilities. This statement is effective
for fiscal years beginning after November 15, 2007. We are in the process
of evaluating the application of the fair value option and its effect on our
results of operations or financial condition.
In
December 2007 the FASB issued SFAS No. 160, Non-controlling
Interests in Consolidated Financial Statements.
SFAS
No. 160 amends Accounting Research Bulletin 51, Consolidated
Financial Statements,
to
establish accounting and reporting standards for the non-controlling interest
in
a subsidiary and for the deconsolidation of a subsidiary. It also clarifies
that
a non-controlling interest in a subsidiary is an ownership interest in the
consolidated entity that should be reported as equity in the consolidated
financial statements. SFAS No. 160 also changes the way the consolidated income
statement is presented by requiring consolidated net income to be reported
at
amounts that include the amounts attributable to both the parent and the
non-controlling interest. It also requires disclosure, on the face of the
consolidated statement of income, of the amounts of consolidated net income
attributable to the parent and to the non-controlling interest. SFAS No. 160
requires that a parent recognize a gain or loss in net income when a subsidiary
is deconsolidated and requires expanded disclosures in the consolidated
financial statements that clearly identify and distinguish between the interests
of the parent owners and the interests of the non-controlling owners of a
subsidiary. SFAS No. 160 is effective for fiscal periods, and interim periods
within those fiscal years, beginning on or after December 15, 2008. The Company
is currently assessing the impact of the adoption of SFAS No. 160 and its impact
on our financial condition, results of operations or cash flows.
In
December 2007 the FASB issued SFAS No. 141R, Business
Combinations.
This
Statement replaces SFAS No. 141 and requires an acquirer in a business
combination to recognize the assets acquired, the liabilities assumed, including
those arising from contractual contingencies, any contingent consideration,
and
any non-controlling interest in the acquiree at the acquisition date, measured
at their fair values as of that date, with limited exceptions specified in
the
Statement. SFAS No. 141R also requires the acquirer in a business combination
achieved in stages (sometimes referred to as a step acquisition) to recognize
the identifiable assets and liabilities, as well as the non-controlling interest
in the acquiree, at the full amounts of their fair values (or other amounts
determined in accordance with SFAS No. 141R). In addition, SFAS No. 141R’s
requirement to measure the non-controlling interest in the acquiree at fair
value will result in recognizing the goodwill attributable to the
non-controlling interest in addition to that attributable to the acquirer.
SFAS
No. 141R amends SFAS No. 109, to require the acquirer to recognize changes
in
the amount of its deferred tax benefits that are recognizable because of a
business combination either in income from continuing operations in the period
of the combination, or directly in contributed capital, depending on the
circumstances. It also amends SFAS No. 142, Goodwill
and Other Intangible Assets,
to
provide guidance on the impairment testing of acquired research and development
intangible assets and assets that the acquirer intends not to use. SFAS No.
141R
applies prospectively to business combinations for which the acquisition date
is
on or after the beginning of the first annual reporting period beginning on
or
after December 15, 2008. The Company is currently assessing the impact of the
adoption of SFAS No. 141R and its impact on our financial condition, results
of
operations or cash flows.
Other
recent accounting pronouncements issued by the FASB (including its Emerging
Issues Task Force), the American Institute of Certified Public Accounts
(“AICPA”) and the SEC did not or are not believed by management to have a
material impact on the Company’s present or future financial
statements.
3. Accounting
for Stock-Based Compensation
Stock
Based Benefit Plans
We
have
stock option plans for executives and key individuals who make significant
contributions to Mitek. The exercise price of options granted to those persons
owning more than 10% of the total combined voting power of the Company’s stock
are not to be less than 110% of the fair market value of the stock as determined
on the date of the grant of the options.
The
1996
plan provides for the purchase of up to 2,000,000 shares of common stock through
incentive and non-qualified options. Options are granted with an exercise price
equal to the fair market value of our stock at the grant date and for a term
of
not more than ten years. Employees owning in excess of 10% of the outstanding
stock are included in the plan on the same terms except that the options must
be
granted for a term of not more than five years. All the options available under
the 1996 plan were granted prior to March of 1999 and no additional options
will
be granted under this plan.
The
1999
plan provides for the purchase of up to 1,000,000 shares of common stock through
incentive and non-qualified options. Incentive stock options are granted with
an
exercise price equal to the fair market value of our stock at the grant date
and
for a term of not more than ten years. Non-qualified stock options may be
granted with an exercise price not less than 85% of fair market value of our
stock at the grant date, and for a term of not more than five years. To date,
we
have elected to grant non-qualified stock option grants under the 1999 plan
with
a three year term.
The
2000
plan provides for the purchase of up to 1,000,000 shares of common stock through
incentive and non-qualified options. Incentive options must be granted with
an
exercise price equal to the fair market value of our stock at the grant date
and
for a term of not more than ten years. Non-qualified stock options may be
granted with an exercise price of not less than 85% of fair market value of
our
stock at the grant date, and for a term of not more than five years. To date,
we
have elected to grant non-qualified stock option grants under the 2000 plan
with
a three year term.
The
2002
plan provides for the purchase of up to 1,000,000 shares of common stock through
incentive and non-qualified options. Incentive options must be granted with
an
exercise price equal to the fair market value of our stock at the grant date
and
for a term of not more than ten years. Non-qualified stock options may be
granted with an exercise price of not less than 85% of fair market value of
our
stock at the grant date, and for a term of not more than five years. To date,
we
have elected to grant non-qualified stock option grants under the 2002 plan
with
a three year term.
The
2006
plan provides for the purchase of up to 1,000,000 shares of common stock through
incentive and non-qualified options. Incentive options must be granted with
an
exercise price equal to the fair market value of our stock at the grant date
and
for a term of not more than ten years. Non-qualified stock options may be
granted with an exercise price of not less than 85% of fair market value of
our
stock at the grant date, and for a term of not more than five years. To date,
we
have elected to grant non-qualified stock option grants under the 2006 plan
with
a three year term.
Adoption
of SFAS 123 (R)
Stock-based
compensation expense recognized during the period is based on the value of
the
portion of share-based payment awards that is ultimately expected to vest during
the period. Stock-based compensation expense recognized in the Company’s
Statement of Operations for the three month period ended December 31, 2007
included compensation expense for share-based payment awards granted prior
to,
but not yet vested as of December 31, 2007 based on the grant date fair value
estimated in accordance with the provisions of SFAS 123 and compensation expense
for the share-based payment awards granted subsequent to September 30, 2006
based on the grant date fair value estimated in accordance with the provisions
of SFAS 123(R). As stock-based compensation expense recognized in the Statement
of Operations for the first three months of fiscal 2008 is based on awards
ultimately expected to vest, it has been reduced for estimated forfeitures.
SFAS
123(R) requires forfeitures to be estimated at the time of grant and revised,
if
necessary, in subsequent periods if actual forfeitures differ from those
estimates. The estimated average forfeiture rates for the three months ended
December 31, 2007 of approximately
14.7% for grants to all employees were based on historical forfeiture
experience. The estimated expected life of option grants for the first three
month period ended December 31, 2007 was 1.8 years on grants to directors and
6
years on grants to employees. In the Company’s pro forma information required
under SFAS 123 for the periods prior to fiscal 2007, the Company accounted
for
forfeitures as they occurred.
SFAS
123R requires the cash flows resulting from the tax benefits resulting from
tax
deductions in excess of the compensation cost recognized for those options
to be
classified as financing cash flows. Due to the Company’s valuation allowance
from losses in the previous years, there were no such tax benefits during the
three month period ended December 31, 2007. Prior to the adoption of SFAS
123(R) those benefits would have been reported as operating cash flows had
the
Company received any tax benefits related to stock option
exercises.
The
fair value of stock-based awards to employees and directors is calculated using
the Black-Scholes option pricing model, even though this model was developed
to
estimate the fair value of freely tradable, fully transferable options without
vesting restrictions, which differ significantly from the Company’s stock
options. The Black-Scholes model requires subjective assumptions, including
future stock price volatility and expected time to exercise, which greatly
affect the calculated values. The expected term of options granted is derived
from historical data on employee exercises and post-vesting employment
termination behavior. The risk-free rate selected to value any particular grant
is based on the U.S Treasury rate that corresponds to the expected life of
the
grant effective as of the date of the grant. The expected volatility is based
on
the historical volatility of the Company’s stock price. These factors could
change in the future, affecting the determination of stock-based compensation
expense in future periods.
Valuation
and Expense Information under SFAS 123(R)
The
value of stock-based compensation is based on the single option valuation
approach under SFAS 123R. It is assumed no dividends will be declared. The
estimated fair value of stock-based compensation awards to employees is
amortized using the straight-line method over the vesting period of the options.
The fair value calculations for stock-based compensation awards to employees
for
the three month periods ended December 31, 2007 and 2006 were based on the
following assumptions:
|
|
Three
Months
Ended
December
31, 2007
|
|
Three
Months
Ended
December
31, 2006
|
|
Risk-free
interest rate
|
|
|
3.50%
- 3.67
|
%
|
|
2.25%
- 5.07
|
%
|
Expected
life (years)
|
|
|
5.3
|
|
|
6
|
|
Expected
volatility
|
|
|
94.19
|
%
|
|
90
|
%
|
Expected
dividends
|
|
|
None
|
|
|
None
|
|
The
following table summarizes stock-based compensation expense related to stock
options under SFAS 123(R) for the three month periods ended December 31,
2007 and 2006 which was allocated as follows:
|
|
Three
Months
Ended
December
31, 2007
|
|
Three
Months
Ended
December
31, 2006
|
|
Research
and development
|
|
$
|
12,225
|
|
$
|
11,329
|
|
Sales
and marketing
|
|
|
9,342
|
|
|
9,004
|
|
General
and administrative
|
|
|
48,733
|
|
|
24,016
|
|
Stock-based
compensation expense related to employee stock options included in
operating expenses
|
|
$
|
70,300
|
|
$
|
44,349
|
|
The
following table summarizes vested and unvested options, fair value per share
weighted average remaining term and aggregate intrinsic value.
|
|
Number
of Shares
|
|
Weighted
Average
Grant Date Fair Value Per Share
|
|
Weighted
Average Remaining contractual life (in Years)
|
|
Aggregate
Intrinsic Value
|
|
December
31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested
|
|
|
2,420,625
|
|
|
0.57
|
|
|
5.72
|
|
|
6,096
|
|
Unvested
|
|
|
1,218,077
|
|
|
0.36
|
|
|
9.64
|
|
|
38,384
|
|
Total
|
|
|
3,638,702
|
|
|
0.57
|
|
|
7.03
|
|
|
44,480
|
|
As
of December 31, 2007, the company had $381,524 of unrecognized compensation
expense expected to be recognized over a weighted average period of
approximately 1.21 years.
A
summary of option activity under the Company’s stock equity plans during the
three months ended December 31, 2007 is as follows:
|
|
Number
of Shares
|
|
Weighted
Average Exercise Price Per Share
|
|
Weighted
Average Remaining Contractual Term (in Years)
|
|
Outstanding,
September 30, 2007
|
|
|
2,510,879
|
|
$
|
0.96
|
|
|
6.39
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted:
|
|
|
|
|
|
|
|
|
|
|
Board
of Directors
|
|
|
175,000
|
|
$
|
.37
|
|
|
|
|
Executive
Officers
|
|
|
600,000
|
|
$
|
.35
|
|
|
|
|
Employees
|
|
|
412,000
|
|
$
|
.35
|
|
|
|
|
Forfeited
|
|
|
(59,177
|
)
|
$
|
.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding,
December 31, 2007
|
|
|
3,638,702
|
|
$
|
.77
|
|
|
7.03
|
|
The
following table summarizes significant ranges of outstanding and exercisable
options as of December 31, 2007:
Range
of
Exercise
Price
|
|
Number
Outstanding
|
|
Weighted
Average Remaining Contractual Life
|
|
Weighted
Average Exercise Price
|
|
Number
Exercisable
|
|
Weighted
Average Exercise Price of Exercisable Options
|
|
Number
Unvested
|
|
$
0.35- - $ 0.69
|
|
|
1,647,111
|
|
|
8.22
|
|
$
|
0.40
|
|
|
687,514
|
|
$
|
0.46
|
|
|
959,597
|
|
$
0.72- - $ 0.92
|
|
|
1,034,545
|
|
|
5.86
|
|
$
|
0.79
|
|
|
776,065
|
|
$
|
0.80
|
|
|
258,480
|
|
$
1.06- - $ 1.68
|
|
|
865,000
|
|
|
6.56
|
|
$
|
1.13
|
|
|
865,000
|
|
$
|
1.13
|
|
|
-
|
|
$
2.13- - $ 2.68
|
|
|
60,525
|
|
|
4.04
|
|
$
|
2.32
|
|
|
60,525
|
|
$
|
2.32
|
|
|
-
|
|
$
3.25- - $12.37
|
|
|
31,521
|
|
|
2.28
|
|
$
|
6.81
|
|
|
31,521
|
|
$
|
6.81
|
|
|
-
|
|
|
|
|
3,638,702
|
|
|
7.03
|
|
$
|
0.77
|
|
|
2,420,625
|
|
$
|
.94
|
|
|
1,218,077
|
|
The
per share weighted average fair value of options granted during the three months
ended December 31, 2007 was $0.30.
4. Income
Taxes
In
July
2006, the FASB issued FASB Interpretation No. 48, "Accounting for Uncertainty
in
Income Taxes" an interpretation of FASB Statement No. 109 ("FIN 48"). FIN 48
clarifies the accounting for uncertainty in income taxes recognized in a
company's financial statements and prescribes a recognition threshold and
measurement attribute for the financial statement recognition and measurement
of
a tax position taken or expected to be taken in a tax return. Further, FIN
48
gives guidance regarding the recognition of a tax position based on a "more
likely than not" recognition threshold; that is, evaluating whether the position
is more likely than not of being sustained upon examination by the appropriate
taxing authorities, based on the technical merits of the position. On October
1,
2007, the Company adopted FIN 48 and the adoption did not impact the Company's
financial condition, results or operations or cash flows.
The
Company is subject to taxation in the United States and various state
jurisdictions. The Company's tax years for 2002 and forward are subject to
examination by the Internal Revenue Service and various state tax
authorities.
At
October 1, 2007, the Company had net deferred tax assets of approximately $6.25
million. The deferred tax assets are primarily comprised of federal and state
net operating loss carryforwards (approximately 83% of the net deferred tax
assets at October 1, 2007). Such carryforwards expire between 2007 and 2025.
Under the Tax reform Act of 1986, the amount of and the benefit from net
operating losses that can be carried forward may be limited in certain
circumstances. The Company carries a deferred tax valuation allowance equal
to
100% of total net deferred assets. In recording this allowance, management
has
considered a number of factors, but chiefly, the Company's recent history of
sustained operating losses. Management has concluded that a valuation allowance
is required for 100% of the total deferred tax assets as it is more likely
than
not that the deferred tax assets will not be realized.
The
Company has not determined the amount of the annual limitation on operating
loss
carryforwards that can be utilized in a taxable year. Any operating loss
carryforwards that will expire prior to utilization as a result of such
limitations will be removed from deferred tax assets with a corresponding
reduction of the valuation allowance. Based on the 100% valuation allowance
on
the deferred tax assets, the Company does not anticipate that future changes
in
the Company's unrecognized tan benefits will impact its effective tax
rate.
The
Company's policy is to classify interest and penalties related to income tax
matters as income tax expense. The Company had no accrual for interest or
penalties as of October 1, 2007 or December 31, 2007, and has not recognized
interest and/or penalties in the statement of operations for the first three
months of 2007.
5. Commitments
and Contingencies
Leases
- Our
office is leased under a non-cancelable operating lease. The lease costs are
expensed on a straight-line basis over the lease term. In September 2005, we
signed a lease with an initial term of seven years for a property located at
8911 Balboa Avenue, San Diego, California. The lease was effective and binding
on the parties as of September 19, 2005; however, the term of the lease began
on
December 9, 2005, which was the date on which the Landlord achieved substantial
completion of certain improvements in accordance with the terms of the Lease
(the "Commencement Date"). The lease will be terminable by the Company after
the
calendar month which is forty-eight (48) full calendar months after the
Commencement Date; however, termination will require certain penalties to be
paid equal to two months of base rent and all unamortized improvements and
commissions. As of the date of this financial statement, the Company does not
have any intent to terminate this lease.
6. Related
Party Transactions
John
H.
Harland Company (“John Harland”) made an investment in the Company in February
and May 2005, as discussed in detail in the Company’s annual 10K-SB filing for
the year ended September 30, 2007, found at Note 7 under Related Party
Transactions. John Harland acquired a total of 2,142,856 shares of unregistered
common stock for an aggregate purchase price of $1,500,000 or $0.70 per share.
As part of the acquisition of shares, John Harland received warrants to purchase
321,428 additional shares of common stock at $0.70 per share. This transaction
resulted in John H. Harland Company and its subsidiary, Harland Financial
Solutions, (collectively “John Harland”) being considered related parties. John
Harland is not involved in the management decisions of the Company and does
not
participate in any board meetings, unless invited.
In
the
first quarter of fiscal 2008, we realized revenue of approximately $236,000
with
Harland Financial Solutions for software licenses and related software maintenance.
In the first quarter of fiscal 2007, we realized revenue of approximately
$80,000 with John Harland for maintenance on engineering development services.
In addition, we realized revenue of approximately $30,000 for software licenses
and related software maintenance with Harland Financial Solutions. At December
31, 2007, there was an outstanding receivable balance from Harland Financial
Solutions of approximately $222,000.
7. Product
Revenues and Sales Concentrations
Product
Revenues - During the three months ended December 31, 2007 and 2006, our
revenues were derived primarily from the Character Recognition Product line.
Below is a summary of the revenues by product lines:
|
|
Three
Months Ended
December
31
|
|
Revenue
|
|
2007
|
|
2006
|
|
(000’s)
|
|
|
|
|
|
Recognition
Toolkits
|
|
$
|
785
|
|
$
|
903
|
|
Document
and Image Processing Solutions
|
|
|
0
|
|
|
12
|
|
Professional
services, Maintenance and other
|
|
|
479
|
|
|
524
|
|
Total
Revenue
|
|
$
|
1,264
|
|
$
|
1,439
|
|
Sales
Concentration - The Company sells its products primarily to community depository
institutions. For the three months ended December 31, 2007 and 2006, the Company
had the following sales concentrations:
|
|
Three
Months Ended
December
31, 2007
|
|
Three
Months Ended
December
31, 2006
|
|
Customers
to which
sales were in excess of 10% of total sales |
|
|
|
|
|
|
|
Number
of customers
|
|
|
2
|
|
|
4
|
|
Aggregate
percentage of sales
|
|
|
39
|
%
|
|
58
|
%
|
Accounts
receivable to the customers in which sales were in excess of 10% of total sales
was approximately $433,000 as of December 31, 2007. Sales to these customers
including related parties during the three months ended December 31, 2007 and
2006 were approximately $488,000 and $824,000, respectively.
ITEM
2
MANAGEMENT’S
DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
Management’s
Discussion
In
addition to historical information, this Management’s Discussion and Analysis
(the “MD&A”) contains certain forward-looking statements within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section 21E of
the
Securities Exchange Act of 1934, as amended. As contained herein, the words
"expects," "anticipates," "believes," "intends," "will," and similar types
of
expressions identify forward-looking statements, which are based on information
that is currently available to us, speak only as of the date hereof, and are
subject to certain risks and uncertainties. To the extent that the MD&A
contains forward-looking statements regarding the financial condition, operating
results, business prospects or any other aspect of the Company, please be
advised that our actual financial condition, operating results and business
performance may differ materially from that projected or estimated by us in
forward-looking statements. We have attempted to identify certain of the factors
that we currently believe may cause actual future experiences and results to
differ from our current expectations. The difference may be caused by a variety
of factors, including, but not limited, to the following: (i) adverse economic
conditions; (ii) decreases in demand for our products and services; (iii)
intense competition, including entry of new competitors into our markets; (iv)
increased or adverse federal, state and local government regulation; (v) our
inability to retain our working capital or otherwise obtain additional capital
on terms satisfactory to us; (vi) increased or unexpected expenses; (vii) lower
revenues and net income than forecast; (viii) price increases for supplies;
(ix)
inability to raise prices; (x) the risk of litigation and/or administrative
proceedings involving us and our employees; (xi) higher than anticipated labor
costs; (xii) adverse publicity or news coverage regarding us; (xiii) inability
to successfully carry out marketing and sales plans; (xiv) loss of key
executives; (xv) inflationary factors; and (xvii) other specific risks that
may
be alluded to in this MD&A.
Our
strategy for fiscal 2008 is to grow the identified markets for our new products
and enhance the functionality and marketability of our image
based recognition and forgery detection technologies. In particular,
Mitek is determined to expand the installed base of its Recognition Toolkits
and
leverage existing technology by devising recognition-based applications to
detect potential fraud and loss at financial institutions. We also
seek to expand the installed base of our Check Forgery
detection solutions by entering into reselling relationships with key
resellers who will better penetrate the market and provide Mitek entrée into a
larger base of community banks.
APPLICATION
OF CRITICAL ACCOUNTING POLICIES
Mitek’s
financial statements and accompanying notes are prepared in accordance with
accounting principles generally accepted in the United States of America.
Preparing financial statements requires management to make estimates and
assumptions that affect the reported amounts of assets, liabilities, revenue,
and expenses. These estimates by management are affected by management’s
application of accounting policies, are subjective and may differ from actual
results. Critical accounting policies for Mitek include revenue recognition,
allowance for doubtful accounts receivable, fair value of equity instruments
and
accounting for income taxes.
Revenue
Recognition
We
enter
into contractual arrangements with integrators, resellers and end users that
may
include licensing of our software products, product support and maintenance
services, consulting services, resale of third-party hardware, or various
combinations thereof, including the sale of such products or services
separately. Our accounting policies regarding the recognition of revenue for
these contractual arrangements are fully described in the Notes to the Financial
Statements, filed with Form 10K-SB for the year ended September 30,
2007.
We
consider many factors when applying generally accepted accounting principles
to
revenue recognition. These factors include, but are not limited to:
· |
The
actual contractual terms, such as payment terms, delivery dates,
and
pricing of the various product and service elements of a
contract
|
· |
Time
period over which services are to be
performed
|
· |
Creditworthiness
of the customer
|
· |
The
complexity of customizations to our software required by service
contracts
|
· |
The
sales channel through which the sale is made (direct, VAR, distributor,
etc.)
|
· |
Discounts
given for each element of a
contract
|
· |
Any
commitments made as to installation or implementation “go live”
dates
|
Each
of
the relevant factors is analyzed to determine its impact, individually and
collectively with other factors, on the revenue to be recognized for any
particular contract with a customer. Management is required to make judgments
regarding the significance of each factor in applying the revenue recognition
standards. Any misjudgment or error by management in its evaluation of the
factors and the application of the standards, especially with respect to complex
or new types of transactions, could have a material adverse affect on our future
revenues and operating results.
Accounts
Receivable.
We
constantly monitor collections from our customers and maintain a provision
for
estimated credit losses that is based on historical experience and on specific
customer collection issues. While such credit losses have historically been
within our expectations and the provisions established, we cannot guarantee
that
we will continue to experience the same credit loss rates that we have in the
past. Since our revenue recognition policy requires customers to be deemed
creditworthy, our accounts receivable are based on customers whose payment
is
reasonably assured. Our accounts receivable are derived from sales to a wide
variety of customers. We do not believe a change in liquidity of any one
customer or our inability to collect from any one customer would have a material
adverse impact on our financial position.
Fair
Value of Equity Instruments
The
valuation of certain items, including valuation of warrants, beneficial
conversion feature related to convertible debt and compensation expense related
to stock options granted, involve significant estimates with underlying
assumptions judgmentally determined. The valuation of warrants and stock options
are based upon a Black Scholes valuation model, which involve estimates of
stock
volatility, expected life of the instruments and other assumptions.
Deferred
Income Taxes.
Deferred
income taxes reflect the net tax effects of temporary differences between the
carrying amounts of assets and liabilities for financial reporting purposes
and
the amounts used for income tax purposes. We maintain a valuation allowance
against the deferred tax asset due to uncertainty regarding the future
realization based on historical taxable income, projected future taxable income,
and the expected timing of the reversals of existing temporary differences.
Until such time as we can demonstrate that we will no longer incur losses or
if
we are unable to generate sufficient future taxable income we could be required
to maintain the valuation allowance against our deferred tax
assets.
RISK
FACTORS
This
Quarterly Report on Form 10-QSB contains statements that are forward-looking.
These statements are based on current expectations and assumptions that are
subject to risks and uncertainties. Actual results could differ materially
because of issues and uncertainties such as those listed below and elsewhere
in
this report, which, among others, should be considered in evaluating our
financial outlook.
Risks
Associated With Our Business
Because
most of our revenues are from a single type of technology, our product
concentration may make us especially vulnerable to market demand and competition
from other technologies, which could reduce our sales and revenues and cause
us
to be unable to continue our business.
We
currently derive substantially all of our product revenues from licenses and
sales of software products incorporating our character recognition technology.
As a result, factors adversely affecting the pricing of or demand for our
products and services, such as competition from other products or technologies,
any decline in the demand for automated entry of hand printed characters,
negative publicity or obsolescence of the software environments in which our
products operate could result in lower sales or gross margins and would have
a
material adverse effect on our business, operating results and financial
condition.
Competition
in our market may result in pricing pressures, reduced margins or the inability
of our products and services to achieve market acceptance.
We
compete against numerous other companies which address the character recognition
market, many of which have greater financial, technical, marketing and other
resources. Other companies could choose to enter our marketplace. We may be
unable to compete successfully against our current and potential competitors,
which may result in price reductions, reduced margins and the inability to
achieve market acceptance for our products. Moreover, from time to time, our
competitors or we may announce new products or technologies that have the
potential to replace our existing product offerings. There can be no assurance
that the announcement of new product offerings will not cause potential
customers to defer purchases of our existing products, which could adversely
affect our business, operating results and financial condition.
We
must continue extensive research and development in order to remain competitive.
If our products fail to gain market acceptance, our business, operating results
and financial condition would be materially adversely affected by the lower
sales.
Our
ability to compete effectively with our character recognition product line
will
depend upon our ability to meet changing market conditions and develop
enhancements to our products on a timely basis in order to maintain our
competitive advantage. Rapidly advancing technology and rapidly changing user
preferences characterize the markets for products incorporating character
recognition technology. Our continued growth will ultimately depend upon our
ability to develop additional technologies and attract strategic alliances
for
related or separate product lines. There can be no assurance that we will be
successful in developing and marketing product enhancements and additional
technologies, that we will not experience difficulties that could delay or
prevent the successful development, introduction and marketing of these
products, or that our new products and product enhancements will adequately
meet
the requirements of the marketplace, will be of acceptable quality, or will
achieve market acceptance.
If
our
new products fail to gain market acceptance, our business, operating results
and
financial condition would be materially adversely affected by the lower sales.
If we are unable, for technological or other reasons, to develop and introduce
products in a timely manner in response to changing market conditions or
customer requirements, our business, operating results and financial condition
may be materially and adversely affected by lower sales.
Our
annual and quarterly results have fluctuated greatly in the past and will likely
continue to do so, which may cause substantial fluctuations in our common stock
price.
Our
quarterly operating results have in the past and may in the future vary
significantly depending on factors including the timing of customer projects
and
purchase orders, new product announcements and releases by us and other
companies, gain or loss of significant customers, price discounting of our
products, the timing of expenditures, customer product delivery requirements,
availability and cost of components or labor and economic conditions generally
and in the information technology market specifically. Any unfavorable change
in
these or other factors could have a material adverse effect on our operating
results for a particular quarter or year, which may cause downward pressure
on
our common stock price. We expect quarterly and annual fluctuations to continue
for the foreseeable future.
We
may need to raise additional capital to fund continuing operations. If our
financing efforts are not successful, we will need to explore alternatives
to
continue operations, which may include a merger, asset sale, joint venture,
loans or further expense reductions. If these measures are not successful,
we
may be unable to continue our operations.
Our
efforts to reduce expenses and generate revenue may not be successful. We have
funded our operations in the past by raising capital, selling certain assets
and
obtaining loans. If our revenues do not increase we will need to raise
additional capital through equity or debt financing or through the establishment
of other funding facilities in order to keep funding operations.
However,
raising capital has been, and will continue to be difficult, and we may not
receive sufficient funding. Any future financing that we seek may not be
available in amounts or at times when needed, or, even if it is available,
may
not be on terms acceptable to us. Also, if we raise additional funds by selling
equity or equity-based securities, the percentage ownership of our existing
stockholders will be reduced and such equity securities may have rights,
preferences or privileges senior to those of the holders of our common stock.
Any inability to obtain additional cash as needed could have a material adverse
effect on our financial position, results of operations and ability to continue
in existence.
Our
historical order flow patterns, which we expect to continue, have caused
forecasting difficult for us. If we do not meet our forecasts or analysts’
forecasts for us, the price of our common stock may
decline.
Historically,
a significant portion of our sales have resulted from shipments during the
last
few weeks of the quarter from orders received in the last month of the
applicable quarter. We do, however, base our expense levels, in significant
part, on our expectations of future revenue. As a result, we expect our expense
levels to be relatively fixed in the short term. Any concentration of sales
at
the end of the quarter may limit our ability to plan or adjust operating
expenses. Therefore, if anticipated shipments in any quarter do not occur or
are
delayed, expenditure levels could be disproportionately high as a percentage
of
sales, and our operating results for that quarter would be adversely affected.
As a result, we believe that period-to-period comparisons of our results of
operations are not and will not necessarily be meaningful, and you should not
rely upon them as an indication of future performance. If our operating results
for a quarter are below the expectations of public market analysts and
investors, the price of our common stock may be materially adversely
affected.
Revenue
recognition accounting standards and interpretations may change, causing us
to
recognize lower revenues.
In
October 1997, the American Institute of Certified Public Accountants (AICPA)
issued Statement of Position (SOP) No. 97-2, Software
Revenue Recognition.
We
adopted SOP 97-2, as amended by SOP 98-4 Deferral of the Effective Date of
a
Provision of SOP 97-2 as of July 1, 1998. In December 1998, the AICPA issued
SOP
98-9, Modification of SOP 97-2, Software Revenue Recognition, With Respect
to
Certain Transactions. We adopted SOP 98-9 on January 1, 2000. These standards
address software revenue recognition matters primarily from a conceptual level
and do not include specific implementation guidance. We believe that we are
currently in compliance with SOP 97-2 and SOP 98-9. In addition, in December
1999, the Securities and Exchange Commission (SEC) staff issued Staff Accounting
Bulletin No. 101, Revenue Recognition in Financial Statements (SAB 101), which
provides further guidance with regard to revenue recognition, presentation
and
disclosure. We adopted SAB 101 during the fourth quarter of fiscal 2000 which
was subsequently superceded by SAB 104.
The
accounting profession and the SEC continue to discuss certain provisions of
SOP
97-2, SAB 104 and other revenue recognition standards and related
interpretations with the objective of providing additional guidance on potential
application of the standards and interpretations. These discussions could lead
to unanticipated changes in revenue recognition standards and, as a result,
in
our current revenue accounting practices, which could cause us to recognize
lower revenues and lead to a decrease in our stock price.
If
our products have product defects, it could damage our reputation, sales,
profitability and result in other costs, any of which could adversely affect
our
operating results which could cause our common stock price to go
down.
Our
products are extremely complex and are constantly being modified and improved,
and as such they may contain undetected defects or errors when first introduced
or as new versions are released. As a result, we have in the past and could
in
the future face loss or delay in recognition of revenues as a result of software
errors or defects. In addition, our products are typically intended for use
in
applications that are critical to a customer's business. As a result, we believe
that our customers and potential customers have a greater sensitivity to product
defects than the market for software products generally.
There
can
be no assurance that, despite our testing, errors will not be found in new
products or releases after commencement of commercial shipments, resulting
in
loss of revenues or delay in market acceptance, diversion of development
resources, damage to our reputation, adverse litigation, or increased service
and warranty costs, any of which would have a material adverse effect upon
our
business, operating results and financial condition.
Our
success and our ability to compete are dependent, in part, upon protection
of
our proprietary technology. If we are unable to protect our proprietary
technology, our revenues and operating results would be materially adversely
affected.
We
generally rely on trademark, trade secret, copyright and patent law to protect
our intellectual property. We may also rely on creative skills of our personnel,
new product developments, frequent product enhancements and reliable product
maintenance as means of protecting our proprietary technologies. There can
be no
assurance, however, that such means will be successful in protecting our
intellectual property. There can be no assurance that others will not develop
technologies that are similar or superior to our technology.
The
source code for our proprietary software is protected both as a trade secret
and
as a copyrighted work. Despite these precautions, it may be possible for a
third
party to copy or otherwise obtain and use our products or technology without
authorization, or to develop similar technology independently.
We
may have difficulty protecting our proprietary technology in countries other
than the United States. If we are unable to protect our proprietary technology,
our revenues and operating results would be materially adversely
affected.
We
operate in a number of countries other than the United States. Effective
copyright and trade secret protection may be unavailable or limited in certain
countries. Moreover, there can be no assurance that the protection provided
to
our proprietary technology by the laws and courts of foreign nations against
piracy and infringement will be substantially similar to the remedies available
under United States law. Any of the foregoing considerations could result in
a
loss or diminution in value of our intellectual property, which could have
a
material adverse effect on our business, financial condition, and results of
operations.
Companies
may claim that we infringe their intellectual property or proprietary rights,
which could cause us to incur significant expenses or prevent us from selling
our products.
We
have
in the past had companies claim that certain technologies incorporated in our
products infringe their patent rights. Although we have resolved the past claims
and there are currently no claims of infringement pending against us, there
can
be no assurance that we will not receive notices in the future from parties
asserting that our products infringe, or may infringe, those parties'
intellectual property rights. There can be no assurance that licenses to
disputed technology or intellectual property rights would be available on
reasonable commercial terms, if at all.
Furthermore,
we may initiate claims or litigation against parties for infringement of our
proprietary rights or to establish the validity of our proprietary rights.
Litigation, either as plaintiff or defendant, could result in significant
expense to us and divert the efforts of our technical and management personnel
from operations, whether or not such litigation is resolved in our favor. In
the
event of an adverse ruling in any such litigation, we might be required to
pay
substantial damages, discontinue the use and sale of infringing products, expend
significant resources to develop non-infringing technology or obtain licenses
to
infringing technology. In the event of a successful claim against us and our
failure to develop or license a substitute technology, our business, financial
condition and results of operations would be materially and adversely
affected.
We
depend upon our key personnel.
Our
future success depends in large part on the continued service of our key
technical and management personnel. We do not have employment contracts with,
or
"key person" life insurance policies on, any of our employees, including Mr.
James B. DeBello, our President and Chief Executive Officer, Mr. John M.
Thornton, our Chairman and Mr. Tesfaye Hailemichael, our Chief Financial
Officer. Loss of services of key employees could have a material adverse effect
on our operations and financial condition. We are also dependent on our ability
to identify, hire, train, retain and motivate high quality personnel, especially
highly skilled engineers involved in the ongoing developments required to refine
our technologies and to introduce future applications. The high technology
industry is characterized by a high level of employee mobility and aggressive
recruiting of skilled personnel.
We
cannot
assure you that we will be successful in attracting, assimilating and retaining
additional qualified personnel in the future. If we were to lose the services
of
one or more of our key personnel, or if we failed to attract and retain
additional qualified personnel, it could materially and adversely affect our
customer relationships, competitive position and revenues.
We
do not have a current credit facility.
While
we
believe that our current cash on hand and cash generated from operations, is
sufficient to finance our operations for the next twelve months, we can make
no
assurance that we will not need additional financing during the next twelve
months or beyond. Actual sales, expenses, market conditions or other factors
which could have a material affect upon us could require us to obtain additional
financing. If such financing is not available, or if available, is not on
reasonable terms, it could have a material adverse effect upon our results
of
operations and financial condition.
The
liability of our officers and directors is limited pursuant to Delaware
law.
Pursuant
to our Certificate of Incorporation, and as authorized under applicable Delaware
Law, our directors and officers are not liable for monetary damages for breach
of fiduciary duty, except for liability (i) for any breach of the director's
duty of loyalty to the corporation or its stockholders, (ii) for acts or
omissions not in good faith or that involve intentional misconduct or a knowing
violation of law, (iii) under Section 174 of the Delaware General Corporation
Law or (iv) for any transaction from which the director derived an improper
personal benefit.
Risks
Related to Our Stock
A
few of our stockholders have significant control over our voting stock which
may
make it difficult to complete some corporate transactions without their support
and may prevent a change in control.
As
of
December 31, 2007, John M. Thornton, who is our Chairman of the Board and his
spouse, Director Sally B. Thornton, beneficially owned 2,919,959 shares of
common stock including stock options or approximately 17% of our outstanding
common stock. Our directors and executive officers as a whole, own approximately
16% of our outstanding common stock, or approximately 31% including outstanding
options (vested and unvested) to acquire common stock. John H. Harland Company
(“John Harland”) has 2,142,856 shares of common stock or approximately 13% of
our outstanding common stock. John Harland also holds 321,428 warrants which
may
be exercised to acquire 321,428 shares of common stock, thereby increasing
the
number of shares of common stock held by John Harland to 2,464,284 shares or
approximately 15% of our outstanding common stock. Laurus Funds may acquire
up
to 1,060,000 shares of common stock upon exercise of its warrant or
approximately 6% of the outstanding common stock.
The
above-described significant stockholders may have considerable influence over
the outcome of all matters submitted to our stockholders for approval, including
the election of directors. In addition, this ownership could discourage the
acquisition of our common stock by potential investors and could have an
anti-takeover effect, possibly depressing the trading price of our common
stock.
Our
common stock is listed on the Over-The-Counter Bulletin
Board.
Our
common stock is currently listed on the Over-The-Counter Bulletin Board
(the “OTCBB”). If our common stock became ineligible to be listed on the
OTCBB, it would likely continue to be listed on the "pink sheets." Securities
traded on the OTCBB or the "pink sheets" are subject to certain securities
regulations. These regulations may limit, in certain circumstances, certain
trading activities in our common stock, which could reduce the volume of trading
in our common stock or the market price of our common stock. The OTC market
and
the "pink sheets" also typically exhibit extreme price and volume fluctuations.
These broad market factors may materially adversely affect the market price
of
our common stock, regardless of our actual operating performance. In the past,
individual companies whose securities have exhibited periods of volatility
in
their market price have had securities class action litigation instituted
against that company. This type of litigation, if instituted, could result
in
substantial costs and a diversion of management's attention and
resources.
We
may issue preferred stock, which could adversely affect the rights of common
stock holders.
The
Board
of Directors is authorized to issue up to 1,000,000 shares of preferred stock
and to determine the price, rights, preferences, privileges and restrictions,
including voting rights, of those shares without any further vote or action
by
the stockholders. The rights of the holders of common stock will be subject
to,
and may be adversely affected by, the rights of the holders of any preferred
stock that may be issued in the future. The issuance of preferred stock, while
providing desirable flexibility in connection with possible acquisitions and
other corporate purposes, could have the effect of making it more difficult
for
a third party to acquire a majority of our outstanding voting stock. We have
no
current plans to issue shares of preferred stock.
Our
common stock price has been volatile. You may not be able to sell your shares
of
our common stock for an amount equal to or greater than the price at which
you
acquire your shares of common stock.
The
market price of our common stock has been, and is likely to continue to be,
highly volatile. Future announcements concerning us or our competitors,
quarterly variations in operating results, announcements of technological
innovations, the introduction of new products or changes in the product pricing
policies of the Company or its competitors, claims of infringement of
proprietary rights or other litigation, changes in earnings estimates by
analysts or other factors could cause the market price of our common stock
to
fluctuate substantially. In addition, the stock market has from time-to-time
experienced significant price and volume fluctuations that have particularly
affected the market prices for the common stocks of technology companies and
that have often been unrelated to the operating performance of particular
companies. These broad market fluctuations may adversely affect the market
price
of our common stock. During the fiscal year ended September 30, 2007, our common
stock price ranged from $0.49 to $1.55. During the three months ended December
31, 2007, our common stock price ranged from $0.31 to $0.60.
Applicable
SEC Rules governing the trading of “penny stocks” limit the trading and
liquidity of our common stock which may adversely affect the trading price
of
our common stock.
Our
common stock currently trades on the OTC Bulletin Board. Since our common stock
continues to trade below $5.00 per share, our common stock is considered a
“penny stock” and is subject to SEC rules and regulations that impose
limitations upon the manner in which our shares can be publicly traded. These
regulations require the delivery, prior to any transaction involving a penny
stock, of a disclosure document explaining the penny stock market and the
associated risks. Under these regulations, brokers who recommend penny stocks
to
persons other than established customers or certain accredited investors must
make a special written suitability determination for the purchaser and receive
the purchaser’s written agreement to a transaction prior to sale. These
regulations have the effect of limiting the trading activity of our common
stock
and reducing the liquidity of an investment in our common stock.
We
do not intend to pay dividends in the foreseeable future.
We
have
never declared or paid a dividend on our common stock. We intend to retain
earnings, if any, for use in the operation and expansion of our business and,
therefore, do not anticipate paying any dividends in the foreseeable
future.
ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS:
Comparison
of Three Months Ended December 31, 2007 and 2006
Net
Sales. Net
sales
for the three month period ended December 31, 2007 were approximately
$1,264,000, compared to approximately $1,439,000 for the same period in 2006,
a
decrease of approximately $175,000, or 12%. The decrease was primarily
attributable to decrease in revenue from three of our major customers who made
significant purchases in the first quarter of fiscal 2007.
Revenue
from Harland Financial Solutions for software licenses and related maintenance
was approximately $236,000 for the quarter ended December 31, 2007 compared
with
approximately $110,000 for the same period in fiscal 2006.
Cost
of Sales.
Cost of
Sales for the three month period ended December 31, 2007 was approximately
$175,000 compared to approximately $157,000 for the same period in 2006, an
increase of approximately $18,000 or 11%. The dollar increase was primarily
attributable to the increase in costs related to engineering services. Stated
as
a percentage of net sales, cost of sales were 14% compared to 11% for the same
period in fiscal 2006. The increase as a percentage of sales was primarily
in
costs of sales related to engineering services provided to a new customer.
Operations.
Operations
expenses for the three-month period ended December 31, 2007 were approximately
$24,000, compared to $22,000 for the same period in 2006. Stated as a percentage
of net sales, operations expenses were 2% for the periods ended December 31,
2007 and 2006.
Selling
and Marketing. Selling
and marketing expenses include payroll, employee benefits, and other
headcount-related costs associated with sales and marketing personnel and
advertising, promotions, trade shows, seminars, and other programs. Selling
and
marketing expenses for the three month period ended December 31, 2007 were
approximately $346,000, compared to $255,000 for the same period in 2006, an
increase of approximately $91,000 or 36%. Stated as a percentage of net sales,
selling and marketing expenses were 27% for the period ended December 31, 2007
compared to 18% for the same period in 2006. The dollar increase in expenses
for
the three month period is primarily attributable to
website
design expense and consulting marketing professional services.
Research
and Development. Research
and Development expenses include payroll, employee benefits, consultant expenses
and other headcount-related costs associated with product development. These
costs are incurred to maintain and enhance existing products. We maintain what
we believe to be sufficient staff to maintain our existing product lines,
including development of new, more feature-rich versions of our existing product
lines, as we determine the demands by the marketplace. We also maintain research
personnel, whose efforts are designed to ensure product paths from current
technologies to anticipated future generations of products within our area
of
business.
Research
and development expenses for the three month period ended December 31, 2007
were
approximately $531,000 compared to approximately $502,000 for the same period
in
2006, an increase of approximately $29,000 or 6%. Stated as a percentage of
net
sales, research and development expenses increased to 42% for the period ended
December 31, 2007 compared to 35% for the same period in 2006. The increase
in
expenses for the three month period ended December 31, 2007 was primarily due
to
outsourcing of programming and enhancements of existing products. For the three
month period ended December 31, 2007, approximately $40,000 compared to none
for
the same period ended in fiscal 2007, were spent in research and development
related to contract development and charged to cost of sales-professional
services, education and other.
General
and Administrative. General
and administrative expenses include payroll, employee benefits, and other
headcount-related costs associated with the finance, facilities, and legal
and
other administrative fees. General and administrative expenses for the three
month period ended December 31, 2007 were approximately $472,000 including
an
increase of $25,000 in stock based compensation expense in the quarter, compared
to approximately $796,000 for the same period in 2006, a decrease of
approximately 324,000 or 41%. Stated as a percentage of net sales, general
and
administrative expenses decreased to 37% compared to 55% for the same period
in
2006. The decrease in expenses for the three month period is primarily
attributable to the costs and expenses incurred in the prior year comparable
period relating to the previously planned merger of Parascript, LLC and Mitek
which will not be consummated.
Interest
and Other Income (Expense) - Net. Interest
and other income (expense) for the three-month period ended December 31, 2007
was approximately $3,000 compared to interest and other income (expense) of
approximately ($1,000) for the same period in 2006, a change of approximately
$4,000. In the three month period ended December 31, 2007, the interest expense
was approximately $0 compared to approximately $6,000 for the three month period
ended December 31, 2006.
LIQUIDITY
AND CAPITAL
At
December 31, 2007, the Company had approximately $1,499,000 in cash and cash
equivalents as compared to $2,096,000 at September 30, 2007. Accounts receivable
totaled approximately $879,000, an increase of approximately $337,000 over
the
September 30, 2007 balance of approximately $542,000. The increase in accounts
receivable was primarily the result of sales generated in the latter part of
the
quarter.
We
financed our cash needs during the three months ended December 31, 2007 and
for
the same period ended December 31, 2006 primarily from collections of accounts
receivable and existing cash and cash equivalents.
Net
cash
used in operating activities during the three months ended December 31, 2007
was
approximately $579,000. The primary use of cash from operating activities was
the loss during the three month period of approximately $282,000 and a decrease
of deferred revenue of $209,000 offset by an increase of accounts receivable
of
$337,000, an increase of accounts payable of $76,000, an increase in accrued
liabilities of approximately $55,000, a decrease in prepaid expenses and other
assets of approximately $33,000, non cash expenses of stock based compensation
of approximately $70,000, and depreciation and amortization of fixed assets
for
approximately $10,000. We used part of the cash provided from operating
activities to finance the acquisition of equipment used in our business.
Our
working capital and current ratio was approximately $1,581,000 and 2.83,
respectively, at December 31, 2007, compared to $1,796,000 and 2.91 at September
30, 2007, and total liabilities to equity ratio was .55 to 1 at December 31,
2007 compared to .53 to 1 at September 30, 2007.
There
are
no significant capital expenditures planned for the foreseeable
future.
We
evaluate our cash requirements on a quarterly basis. Historically, we have
managed our cash requirements principally from cash generated from operations
and financing transactions. We believe that we will have sufficient capital
to
finance our operations for the next twelve months using existing cash and cash
equivalents, and cash to be generated from operations.
ITEM
3
CONTROLS
AND PROCEDURES
Under
the
supervision and with the participation of our management, including the Chief
Executive Officer and Chief Financial Officer, we have evaluated the
effectiveness of the design and operation of our disclosure controls and
procedures pursuant to Exchange Act Rule 13a-15 as of the end of the period
covered by this report. Based on that evaluation, the Chief Executive Officer
and Chief Financial Officer have concluded that these disclosure controls and
procedures are effective as of December 31, 2007.
There
have not been any changes in our internal controls over financial reporting
(as
such term is defined in Rules 13a-15(f) and 15d - 15(f) under the Exchange
Act)
during the fiscal quarter ended December 31, 2007 that have materially affected,
or are reasonably likely to materially affect, our internal controls over
financial reporting
PART
II -
OTHER INFORMATION
ITEM
1
LEGAL
PROCEEDINGS
There
are
no additional material legal proceedings pending against the Company not
previously reported by the Company in Item 3 of its Form 10-KSB for the year
ended September 30, 2007, which Item 3 is incorporated herein by
reference.
ITEM
6.
EXHIBITS
AND REPORTS ON FORM 8-K
a. Exhibits:
The
following exhibits are filed herewith:
Exhibit
Number
|
|
Exhibit
Title
|
31.1
|
|
Certification
of Periodic Report by the Chief Executive Officer Pursuant to Rule
13a-14(a) of the Securities Exchange Act of 1934
|
31.2
|
|
Certification
of Periodic Report by the Chief Financial Officer Pursuant to Rule
13a-14(a) of the Securities Exchange Act of 1934
|
32.1
|
|
Certification
of Periodic Report by the Chief Executive Officer Pursuant to Section
906
of the Sarbanes Oxley Act of 2002
|
32.2
|
|
Certification
of Periodic Report by the Chief Financial Officer Pursuant to Section
906
of the Sarbanes Oxley Act of 2002
|
SIGNATURES
|
|
MITEK
SYSTEMS,
INC. |
|
|
|
Date:
February
13, 2008 |
|
/s/ James
B.
DeBello |
|
James
B. DeBello, President and Chief
Executive Officer |
|
|
|
|
|
|
Date:
February
13, 2008 |
|
/s/ Tesfaye
Hailemichael |
|
Tesfaye
Hailemichael |
|
Chief Financial
Officer |